News
Bozeman, Montana based SensoPath Technologies gets contract to continue cancer research
October 23, 2012 /
Local biotechnology company SensoPath Technologies http://www.sensopath.com/ has received a $1.5 million contract from the National Cancer Institute at the National Institutes of Health.
The contract will go toward the company’s Phase II research into its treatment for recurring head and neck cancers.
JASON BACAJ, Business Journal Editor
Full Story: http://www.bozemandailychronicle.com/news/economy/article_5e0e1d8c-1cc6-11e2-a5ea-001a4bcf887a.html
MATR Supporters (view all)
Posted in: Biotech
Sorry, we couldn't find any posts. Please try a different search.